|
ES2278390T3
(es)
*
|
1996-05-23 |
2007-08-01 |
The Scripps Research Institute |
Sistema de presentacion de antigenos de clase ii de cmh y procedimientos de activacion de linfocitos t cd4+.
|
|
US6291430B1
(en)
*
|
1997-09-12 |
2001-09-18 |
Ludwig Institute For Cancer Research |
Mage-3 peptides presented by HLA class II molecules
|
|
AU765085B2
(en)
|
1998-05-11 |
2003-09-11 |
Miltenyi Biotec Gmbh |
Method of direct selection of antigen-specific T cells
|
|
US6230662B1
(en)
|
1998-06-22 |
2001-05-15 |
Theresa Miale |
Animal lift and transport apparatus and method for using the same
|
|
EP1104456A1
(en)
*
|
1998-08-10 |
2001-06-06 |
Chiron Corporation |
Engineered antigen-presenting cells expressing an array of antigens and uses thereof
|
|
US7807377B2
(en)
|
1998-10-20 |
2010-10-05 |
Salvatore Albani |
Method of isolating antigen-specific T cells employing artificial antigen presenting cells
|
|
CA2345277C
(en)
*
|
1998-10-20 |
2011-05-24 |
Salvatore Albani |
Methods for isolation, quantification, characterization and modulation of antigen-specific t cells
|
|
US6225443B1
(en)
*
|
1999-05-19 |
2001-05-01 |
Wisconsin Alumni Research Foundation |
Cytotoxic T lymphocyte epitopes of the major outer membrane protein of chlamydia trachomatis
|
|
US7521202B2
(en)
|
1999-12-17 |
2009-04-21 |
The Board Of Regents Of The University Of Oklahoma |
Method and apparatus for the production of soluble MHC antigens and uses thereof
|
|
US7541429B2
(en)
|
2000-10-10 |
2009-06-02 |
The Board Of Regents Of The University Of Oklahoma |
Comparative ligand mapping from MHC positive cells
|
|
DE10009341A1
(de)
*
|
2000-02-22 |
2001-09-06 |
Florian Kern |
Verfahren zur antigen-spezifischen Stimulation von T-Lymphozyten
|
|
US7572631B2
(en)
|
2000-02-24 |
2009-08-11 |
Invitrogen Corporation |
Activation and expansion of T cells
|
|
US7541184B2
(en)
|
2000-02-24 |
2009-06-02 |
Invitrogen Corporation |
Activation and expansion of cells
|
|
AU2000243137A1
(en)
*
|
2000-04-20 |
2001-11-07 |
Salvatore Albani |
Methods for isolation, quantification, characterization and modulation of antigen-specific t cells
|
|
US20070026433A1
(en)
|
2001-03-09 |
2007-02-01 |
Hildebrand William H |
Epitope testing using soluble HLA
|
|
WO2002056908A2
(en)
*
|
2001-01-16 |
2002-07-25 |
Hildebrand William H |
Artificial antigen-presenting cells
|
|
US7579007B2
(en)
*
|
2001-02-13 |
2009-08-25 |
Jdm Technologies, Inc. |
Production of “biological carriers” for induction of immune responses and inhibition of viral replication
|
|
US20040071671A1
(en)
*
|
2001-02-20 |
2004-04-15 |
Leturcq Didier J. |
Cell therapy method for the treatment of tumors
|
|
ES2643582T3
(es)
*
|
2001-02-20 |
2017-11-23 |
Janssen Pharmaceuticals, Inc. |
Antígeno de Drosophila artificial que presenta célula para preparar suspensión de células CD8 para su uso en el tratamiento del cáncer
|
|
FR2824567B1
(fr)
*
|
2001-05-11 |
2003-08-08 |
Inst Nat Sante Rech Med |
Procede d'obtention de lymphocytes tr1 regulateurs specifiques d'antigene
|
|
US7638326B2
(en)
|
2002-01-03 |
2009-12-29 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of T-cells using an engineered multivalent signaling platform
|
|
US7745140B2
(en)
*
|
2002-01-03 |
2010-06-29 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool
|
|
WO2003057171A2
(en)
*
|
2002-01-03 |
2003-07-17 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of t-cells using an engineered multivalent signaling platform
|
|
US20040072262A1
(en)
*
|
2002-10-11 |
2004-04-15 |
Montero-Julian Felix A. |
Methods and systems for detecting MHC class I binding peptides
|
|
ATE353954T1
(de)
|
2002-10-11 |
2007-03-15 |
Sentoclone Therapeutics Ab |
Immuntherapie für krebs
|
|
US7435592B2
(en)
|
2003-05-13 |
2008-10-14 |
Immunovative Therapies, Ltd. |
Compositions for allogeneic cell therapy
|
|
WO2005047902A1
(en)
*
|
2003-11-03 |
2005-05-26 |
Beckman Coulter, Inc. |
Solution-based methods for detecting mhc-binding peptides
|
|
US7592431B2
(en)
|
2004-02-26 |
2009-09-22 |
Immunovative Therapies, Ltd. |
Biodegradable T-cell Activation device
|
|
CA2555714C
(en)
|
2004-02-26 |
2013-12-03 |
Immunovative Therapies, Ltd. |
Methods for preparing t-cells for cell therapy
|
|
JP2007536522A
(ja)
*
|
2004-05-07 |
2007-12-13 |
ベックマン コールター インコーポレーティッド |
Ｃｔｌの媒介による抗原提示細胞の溶解を検出するためのｍｈｃ架橋系
|
|
WO2005118788A2
(en)
|
2004-05-27 |
2005-12-15 |
The Trustees Of The University Of Pennsylvania |
Novel artificial antigen presenting cells and uses therefor
|
|
EP2226332A1
(en)
*
|
2004-06-17 |
2010-09-08 |
Beckman Coulter, Inc. |
Mycobacterium tuberculosis epitopes and methods of use thereof
|
|
EP1712615A1
(en)
*
|
2005-04-15 |
2006-10-18 |
Txcell |
In vitro production of a cell population using feeder cells
|
|
CA2611861C
(en)
|
2005-06-08 |
2017-11-28 |
The Brigham And Women's Hospital, Inc. |
Methods and compositions for the treatment of persistent infections
|
|
US20100080792A1
(en)
*
|
2005-06-16 |
2010-04-01 |
Dorothee Herlyn |
Method for Identifying a MHC Class II-Dependent Tumor-Associated T Helper Cell Antigen
|
|
US8211425B2
(en)
|
2005-12-21 |
2012-07-03 |
Sentoclone International Ab |
Method for treating disseminated cancer
|
|
AU2006328945B2
(en)
|
2005-12-21 |
2011-06-30 |
Sentoclone International Ab |
Method for treating malignant melanoma
|
|
WO2007071410A1
(en)
|
2005-12-21 |
2007-06-28 |
Sentoclone Ab |
Method for treating urinary bladder cancer
|
|
CA2634167C
(en)
|
2005-12-21 |
2015-06-16 |
Sentoclone Ab |
Improved method for expansion of tumour-reactive t-lymphocytes for immunotherapy of patients with cancer
|
|
CA2643337C
(en)
|
2006-03-01 |
2016-01-12 |
Janssen Pharmaceutica N.V. |
Cancer treatment combining lymphodepleting agent with ctls and cytokines
|
|
JP5543207B2
(ja)
|
2006-10-04 |
2014-07-09 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
不活性化された人工抗原提示細胞の調製および細胞治療におけるそれらの使用
|
|
KR101523391B1
(ko)
*
|
2006-12-27 |
2015-05-27 |
에모리 유니버시티 |
감염 및 종양 치료를 위한 조성물 및 방법
|
|
US20110070154A1
(en)
*
|
2008-08-13 |
2011-03-24 |
Hyde Roderick A |
Artificial cells
|
|
MX2011005691A
(es)
|
2008-11-28 |
2011-07-20 |
Univ Emory |
Metodos para el tratamiento de infecciones y tumores.
|
|
US8075895B2
(en)
|
2009-09-22 |
2011-12-13 |
Janssen Pharmaceutica N.V. |
Identification of antigenic peptides from multiple myeloma cells
|
|
EP2404618A1
(en)
|
2010-07-07 |
2012-01-11 |
Stichting Katholieke Universiteit meer in het bijzonder Radboud Universiteit Nijmegen |
Immunomodulatory protein constructs with a helical polymeric backbone.
|
|
JP5006992B2
(ja)
*
|
2010-08-06 |
2012-08-22 |
株式会社ケーナインラボ |
免疫機能の強化剤
|
|
WO2012151266A1
(en)
|
2011-05-03 |
2012-11-08 |
Michael Har-Noy |
Methods for handling biological drugs containing living cells
|
|
BR112013028285A2
(pt)
|
2011-05-03 |
2017-01-10 |
Immunovative Therapies Ltd |
indução de il-12 usando imunoterapia
|
|
WO2013163171A1
(en)
|
2012-04-24 |
2013-10-31 |
Kaufman Dan S |
Method for developing natural killer cells from stem cells
|
|
EP3783098A1
(en)
|
2013-05-14 |
2021-02-24 |
Board Of Regents, The University Of Texas System |
Human application of engineered chimeric antigen receptor (car) t-cells
|
|
CN106232807A
(zh)
|
2013-12-16 |
2016-12-14 |
美利坚合众国, 由健康及人类服务部部长代表 |
通过使用vlp复制子投递ii类mhc抗原的癌症免疫疗法
|
|
KR102375998B1
(ko)
|
2014-02-14 |
2022-03-21 |
더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 |
키메라 항원 수용체 및 제조방법
|
|
US10857219B2
(en)
|
2014-03-28 |
2020-12-08 |
The Board Of Regents Of The University Of Oklahoma |
Compositions comprising soluble HLA/M. tuberculosis-specific ligand complexes and methods of production and use thereof
|
|
CA2945388A1
(en)
|
2014-04-23 |
2015-10-29 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptors (car) for use in therapy and methods for making the same
|
|
KR20200138445A
(ko)
|
2014-04-24 |
2020-12-09 |
보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 |
입양 세포 요법 생성물을 생성하기 위한 유도 만능 줄기 세포의 응용
|
|
US20170333480A1
(en)
|
2014-11-05 |
2017-11-23 |
Board Of Regents, The University Of Texas System |
Gene modified immune effector cells and engineered cells for expansion of immune effector cells
|
|
CA2964783C
(en)
|
2014-11-05 |
2024-01-23 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptors (car) to selectively target protein complexes
|
|
FR3031519B1
(fr)
|
2015-01-14 |
2016-12-30 |
Arkema France |
Composition a base de terpolymere electroactif
|
|
DK3271382T3
(da)
*
|
2015-03-16 |
2020-05-04 |
Max Delbrueck Centrum Fuer Molekulare Medizin Helmholtz Gemeinschaft |
Fremgangsmåde til detektion af nye immunogene T-celleepitoper og isolering af nye antigenspecifikke T-cellereceptorer ved hjælp af et MHC-cellebibliotek
|
|
EP3368075B1
(en)
|
2015-10-27 |
2020-01-29 |
Board of Regents, The University of Texas System |
Chimeric antigen receptor molecules and uses thereof
|
|
CA3025667A1
(en)
|
2016-06-08 |
2017-12-14 |
Intrexon Corporation |
Cd33 specific chimeric antigen receptors
|
|
JP7062640B2
(ja)
|
2016-07-29 |
2022-05-06 |
ジュノー セラピューティクス インコーポレイテッド |
抗ｃｄ１９抗体に対する抗イディオタイプ抗体
|
|
EP3538112B1
(en)
|
2016-11-09 |
2026-02-25 |
Musc Foundation for Research Development |
Cd38-nad+ regulated metabolic axis in anti-tumor immunotherapy
|
|
EP3568474A1
(en)
|
2017-01-10 |
2019-11-20 |
Intrexon Corporation |
Modulating expression of polypeptides via new gene switch expression systems
|
|
US11285196B2
(en)
|
2017-03-13 |
2022-03-29 |
Eslam Abbas Baseuny |
Multivalent biologic constructs for inducing a therapeutic modulation of cellular response and uses thereof
|
|
SG11201909331UA
(en)
|
2017-04-18 |
2019-11-28 |
Fujifilm Cellular Dynamics Inc |
Antigen-specific immune effector cells
|
|
CA3065930A1
(en)
|
2017-06-07 |
2018-12-13 |
Intrexon Corporation |
Expression of novel cell tags
|
|
JP2021500878A
(ja)
|
2017-10-12 |
2021-01-14 |
ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム |
免疫療法のためのｔ細胞受容体
|
|
US12473336B2
(en)
|
2018-02-21 |
2025-11-18 |
Board Of Regents, The University Of Texas System |
Methods for activation and expansion of natural killer cells and uses thereof
|
|
MX2021006208A
(es)
|
2018-11-28 |
2021-10-01 |
Univ Texas |
Edición por multiplexación del genoma de células inmunitarias para mejorar la funcionalidad y resistencia al entorno supresor.
|
|
MX2021006393A
(es)
|
2018-11-29 |
2021-10-13 |
Univ Texas |
Metodos para expansion ex vivo de celulas exterminadoras naturales y uso de las mismas.
|
|
US20220387493A1
(en)
|
2019-11-06 |
2022-12-08 |
Baylor College Of Medicine |
Method for producing cytotoxic effector memory t-cells for car t-cell treatment of cancer
|
|
US20230079539A1
(en)
|
2020-02-10 |
2023-03-16 |
Board Of Regents, The University Of Texas System |
Methods for rapid cloning and expression of hla class i cells
|
|
CN115715295A
(zh)
|
2020-05-27 |
2023-02-24 |
安逊生物科学股份有限公司 |
将car t细胞重新定向到感兴趣的抗原的衔接分子
|
|
US12275766B2
(en)
|
2020-12-23 |
2025-04-15 |
Janssen Biotech, Inc. |
Neoantigen peptide mimics
|
|
EP4514382A1
(en)
|
2022-04-28 |
2025-03-05 |
Musc Foundation for Research Development |
Chimeric antigen receptor modified regulatory t cells for treating cancer
|